Evidence map›Paper›PMID 35992339›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Effects of

Tinuola Olorunsogbon, Yinka Adesanya, Hasan K Atiyeh, Christopher Chukwudi Okonkwo, Victor Chinomso Ujor, Thaddeus Chukwuemeka Ezeji

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Complete genome sequence ofMicrobiology resource announcements · 2026
    Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Tinuola OlorunsogbonDepartment of Animal Science, The Ohio State University, Wooster, OH, United States.
Yinka AdesanyaBiosystems and Agricultural Engineering, Oklahoma State University, Stillwater, OK, United States.
Hasan K AtiyehBiosystems and Agricultural Engineering, Oklahoma State University, Stillwater, OK, United States.
Christopher Chukwudi OkonkwoBiotechnology Program, College of Science, The Roux Institute, Northeastern University, Portland, ME, United States.
Victor Chinomso UjorDepartment of Food Science, University of Wisconsin-Madison, Maddison, WI, United States.
Thaddeus Chukwuemeka EzejiDepartment of Animal Science, The Ohio State University, Wooster, OH, United States.
Oklahoma State University · USThe Ohio State University · USNortheastern University · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of lignocellulose-derived microbial inhibitory compounds (LDMICs) in lignocellulosic biomass (LB) hydrolysates is a barrier to efficient conversion of LB hydrolysates to fuels and chemicals by fermenting microorganisms. Results from this study provide convincing evidence regarding the effectiveness of metabolically engineered

Indexed as

ABE fermentationammonium carbonateClostridium beijerinckiiLDMICnon-detoxified switchgrass hydrolysateshort-chain dehydrogenase/reductase

Identifiers

PMID35992339
PMCPMC9382077
OpenAlexW4289517824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.